Laquinimod sodium, CAS [[248282-07-7]]

Produktübersicht

• Artikelname: Laquinimod sodium, CAS [[248282-07-7]]
• Artikelnummer: TGM-T61607
• Hersteller Artikelnummer: T61607
• Alternativnummer: TGM-T61607-25MG,TGM-T61607-50MG,TGM-T61607-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Laquinimod (ABR-215062) sodium is a carboxamide derivative administered orally that serves as a powerful immunomodulator, designed to prevent inflammation and neurodegeneration within the central nervous system. This compound effectively diminishes the activation of astrocytic NF-kappaB, offering protection against Cuprizone-induced demyelination. It shows promise for the treatment of both relapsing-remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS, RRMS or CPMS), in addition to its potential applications in the study of neurodegenerative diseases [1] [2] [3] [4].

Produkteigenschaften

• Molekulargewicht: 378.79
• CAS Nummer: [248282-07-7]
• Formel: C19H16ClN2NaO3
• Target-Kategorie: Others|||Apoptosis|||NF-kappaB

Bilder

T61607